Boston Scientific Corporation (LON:0HOY)
London · Delayed Price · Currency is GBP · Price in USD 99.02
+1.64 (1.69%)
Jan 7, 2026, 4:53 PM GMT
Boston Scientific Market Cap
Boston Scientific has a market cap or net worth of 107.39 billion as of January 7, 2026. Its market cap has increased by 5.08% in one year.
Market Cap
107.39B
Enterprise Value
115.55B
Revenue
14.39B
Ranking
n/a
PE Ratio
51.72
Stock Price
99.02
Market Cap Chart
Since May 19, 1992, Boston Scientific's market cap has increased from 876.49M to 107.39B, an increase of 12,152.61%. That is a compound annual growth rate of 15.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 107.39B | 2.26% |
| Dec 31, 2025 | 105.02B | -0.12% |
| Dec 31, 2024 | 105.15B | 58.15% |
| Dec 29, 2023 | 66.49B | 20.88% |
| Dec 30, 2022 | 55.00B | 23.04% |
| Dec 31, 2021 | 44.71B | 18.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.72B |
| GSK plc | 76.21B |
| Haleon | 33.53B |
| Smith & Nephew | 10.67B |
| Convatec Group | 4.76B |
| Hikma Pharmaceuticals | 3.51B |
| HUTCHMED (China) | 1.81B |
| Genus | 1.72B |